GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK/mTORC1 signaling-Reference-Cited by-同舟云学术

GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK/mTORC1 signaling

Published:2020-02-13 Issue:3 Volume:5 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Chen Wen-Lian^ORCID,Jin Xing,Wang Mingsong,Liu Dan,Luo Qin,Tian Hechuan,Cai Lili,Meng Lifei,Bi Rui,Wang Lei,Xie Xiao,Yu Guanzhen,Li Lihui,Dong Changsheng^ORCID,Cai Qiliang,Jia Wei^ORCID,Wei Wenyi^ORCID,Jia Lijun

Funder

National Natural Science Foundation of China

The National Scientific and Technological Major Special Project of China

National Key R&D Program of China

National Thirteenth Five-Year Science and Technology Major Special Project for New Drug Innovation and Development

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/131596/files/pdf

Reference59 articles.

1. Lung cancer: current therapies and new targeted treatments

2. Non-small-cell lung cancers: a heterogeneous set of diseases

3. Lung cancer: understanding its molecular pathology and the 2015 WHO classification;Inamura;Front Oncol,2017

4. Gene aberrations for precision medicine against lung adenocarcinoma

5. Mechanisms of immune evasion and current status of checkpoint inhibitors in non‐small cell lung cancer

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASCT2 Regulates Fatty Acid Metabolism to Trigger Glutamine Addiction in Basal-like Breast Cancer;Cancers;2024-08-30

2. GLUT5-overexpression-related tumorigenic implications;Molecular Medicine;2024-08-06

3. KHK-A promotes fructose-dependent colorectal cancer liver metastasis by facilitating the phosphorylation and translocation of PKM2;Acta Pharmaceutica Sinica B;2024-07

4. Fructose-induced metabolic reprogramming of cancer cells;Frontiers in Immunology;2024-04-22

5. Targeting Pivotal Hallmarks of Cancer for Enhanced Therapeutic Strategies in Triple-Negative Breast Cancer Treatment—In Vitro, In Vivo and Clinical Trials Literature Review;Cancers;2024-04-12